Pharmacokinetic and pharmacodynamic alterations in older people with dementia

References

• Prince M, Wimo A, Guerchet M, et al. World Alzheimer report 2015: the global impact of dementia - an analysis of prevalence, incidence, cost and trends. Alzheimer’s Dis Int. 2015. Available from: https://www.alz.co.uk/research/world-report-2015
   Google Scholar
• Fontana L, Kennedy BK, Longo VD, et al. Medical research: treat ageing. Nature. [Internet]. 2014 [cited 2016 Aug 10];511(7510):405–407. Available from: http://www.mistergui.com/downloads/Medical Research on Ageing.doc
   PubMed Web of Science ®Google Scholar
• Schubert CC, Boustani M, Callahan CM, et al. Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc. 2006;54(1):104–109.
   PubMed Web of Science ®Google Scholar
• Andersen F, Viitanen M, Halvorsen D, et al. Co-morbidity and drug treatment in Alzheimer’s disease. A cross sectional study of participants in the dementia study in Northern Norway. BMC Geriatr. 2011;11(1):58.
   PubMed Web of Science ®Google Scholar
• Lau DT, Mercaldo ND, Harris AT, et al. Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord. 2010 [cited 2009 Jun 30];24(1):56–63.
   PubMed Web of Science ®Google Scholar
• Fereshtehnejad SM, Johnell K, Eriksdotter M. Anti-dementia drugs and co-medication among patients with Alzheimer’s disease: investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem). Drugs Aging. [Internet]. Springer International Publishing. 2014 Mar 5 [cited 2016 Jun 8];31(3):215–224. Available from: http://link.springer.com/10.1007/s40266-014-0154-8
   PubMed Web of Science ®Google Scholar
• Tan ECK, Jokanovic N, Koponen MP, et al. Prevalence of analgesic use in people with and without dementia or cognitive impairment in aged care facilities: a systematic review and meta-analysis. Curr Clin Pharmacol. Bentham Science Publishers. 2015;103:194–203.
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association. 2015 Alzheimer’s disease facts and figures. Alzheimers Dement. [Internet]. 2015 [cited 2016 Jun 27];11(3):332–384. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25984581
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders [Internet]. Fifth edit. American Psychiatric Association. Arlington (VA): American Psychiatric Association; 2013 [cited 2016 Jun 27]. p. 991. Available from: http://psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596
   Google Scholar
• Rockwood K, King Moorhouse P, Song X, et al. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study. J Neurol Sci. 2007;252(2):106–112.
   PubMed Web of Science ®Google Scholar
• Bunn F, Burn A-M, Goodman C, et al. Comorbidity and dementia: a scoping review of the literature. BMC Med. 2014;12(1):192.
   PubMed Web of Science ®Google Scholar
• Ferrucci L, Guralnik JM, Studenski S, et al. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. [Internet]. Blackwell Science Inc. 2004 Apr [cited 2016 Jun 27];52(4):625–634. Available from: http://doi.wiley.com/10.1111/j.1532-5415.2004.52174.x
   PubMed Web of Science ®Google Scholar
• McMurdo MET, Witham MD, Gillespie ND. Including older people in clinical research. BMJ. [Internet]. BMJ Group. 2005 Nov 5 [cited 2016 Jun 27];331(7524). 1036–1037. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16269472
   PubMed Web of Science ®Google Scholar
• Zulman DM, Sussman JB, Chen X, et al. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials [Internet]. J Gen Intern Med. 2011;783–790. Available from: http://link.springer.com/article/10.1007/s11606-010-1629-x
   Google Scholar
• Jongsma KR, Van Bruchem-Visser RL, van de Vathorst S, et al. Has dementia research lost its sense of reality? A descriptive analysis of eligibility criteria of Dutch dementia research protocols. Neth J Med. [Internet]. 2016 Jun [cited 2016 Jun 23];74(5):201–209. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27323673
   PubMed Web of Science ®Google Scholar
• Banzi R, Camaioni P, Tettamanti M, et al. Older patients are still under-represented in clinical trials of Alzheimer’s disease. Alzheimers Res Ther. [Internet]. BioMed Central. 2016 Dec 12 [cited 2016 Aug 25];8(1). 32. Available from: http://alzres.biomedcentral.com/articles/10.1186/s13195-016-0201-2
   PubMed Web of Science ®Google Scholar
• Alzheimer Association. 2016 Alzheimer’s disease facts and figures. Alzheimer’s Dement 2016. [Internet]. 2016 [cited 2016 Jul 27];12(4):1–80. Available from: http://www.alz.org/facts/overview.asp#quickFacts
   PubMedGoogle Scholar
• Australian Institute of Health and Welfare. Dementia in Australia. Cat. no. AGE 70. [Internet]. Canberra: AIHW; 2012. Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737422943
   Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Ser A-BIOLOGICAL Sci Med Sci. [Internet]. 2001 [cited 2016 Jul 11];56(3):M146–56. Available from: http://biomedgerontology.oxfordjournals.org/content/56/3/M146.short
   PubMed Web of Science ®Google Scholar
• Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J. [Internet]. 2005 [cited 2016 Jul 27];173(5):489–495. Available from: https://www.cmaj.ca/content/173/5/489.full
   PubMed Web of Science ®Google Scholar
• Collard RM, Boter H, Schoevers RA, et al. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. [Internet]. 2012 Aug [cited 2016 Aug 31];60(8):1487–1492. Available from: http://doi.wiley.com/10.1111/j.1532-5415.2012.04054.x
   PubMed Web of Science ®Google Scholar
• Buchman AS, Boyle PA, Wilson RS, et al. Frailty is associated to with incident Alzheimer’s disease and cognitive decline in elderly. Psychosommed. [Internet]. 2007 [cited 2016 Jul 27];69:483–489. Available from: http://journals.lww.com/psychosomaticmedicine/Abstract/2007/06000/Frailty_is_Associated_With_Incident_Alzheimer_s.13.aspx
   PubMed Web of Science ®Google Scholar
• Armstrong JJ, Mitnitski A, Andrew MK, et al. Cumulative impact of health deficits, social vulnerabilities, and protective factors on cognitive dynamics in late life: a multistate modeling approach. Alzheimers Res Ther. [Internet]. BioMed Central. 2015 Dec 5 [cited 2016 Jul 27];7(1):38. Available from: http://alzres.com/content/7/1/38
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Scafato E, Seripa D, et al. Reversible cognitive frailty, dementia, and all-cause mortality. The Italian longitudinal study on aging. J Am Med Dir Assoc. 2017;18(1):89.e1–89.e8.
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Scafato E, Frisardi V, et al. Frailty syndrome and the risk of vascular dementia: the Italian longitudinal study on aging. Alzheimer’s Dement. 2013;9(2):113–122.
   PubMed Web of Science ®Google Scholar
• Avila-Funes J, Carcaillon L, Helmer C, et al. Is frailty a prodromal stage of vascular dementia? Results from the three-city study. J Am Geriatr Soc. 2012;60(9):1708–1712.
   PubMed Web of Science ®Google Scholar
• Han ES, Lee Y, Kim J. Association of cognitive impairment with frailty in community-dwelling older adults. Int Psychogeriatr. [Internet]. 2014 Oct 23 [cited 2016 Jul 27];26(1):155–163. Available from: http://www.journals.cambridge.org/abstract_S1041610213001841
   PubMed Web of Science ®Google Scholar
• Jacobs JM, Cohen A, Ein-Mor E, et al. Frailty, cognitive impairment and mortality among the oldest old. J Nutr Heal Aging. Springer-Verlag. 2011;158:678–682.
   PubMed Web of Science ®Google Scholar
• Hoover M, Rotermann M, Sanmartin C, et al. Validation of an index to estimate the prevalence of frailty among community-dwelling seniors. Heal Rep. [Internet]. 2013 [cited 2016 Sep 16];24(9):10–17. Available from: http://search.proquest.com/openview/020ace186b0844886d45ed72bb14063c/1?pq-origsite=gscholar
   PubMed Web of Science ®Google Scholar
• Matusik P, Tomaszewski K, Chmielowska K, et al. Severe frailty and cognitive impairment are related to higher mortality in 12-month follow-up of nursing home residents. Arch Gerontol Geriatr. [Internet]. 2012 [cited 2016 Jul 27];55(1):22–24. Available from: http://www.sciencedirect.com/science/article/pii/S0167494311001890
   PubMed Web of Science ®Google Scholar
• González-Vaca J, De La Rica-Escuín M, Silva-Iglesias M, et al. Frailty in institutionalized older adults from albacete. The Final study: rationale, design, methodology, prevalence and attributes. Maturitas. [Internet]. 2014 [cited 2016 Jul 27];77(1):78–84. Available from: http://www.sciencedirect.com/science/article/pii/S0378512213003150
   PubMed Web of Science ®Google Scholar
• Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–194.
   PubMed Web of Science ®Google Scholar
• Kelaiditi E, Cesari M, Canevelli M, et al. Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Heal Aging. 2013;17(9):726–734.
   PubMed Web of Science ®Google Scholar
• Montero-Odasso M, Barnes B, Speechley M, et al. Disentangling cognitive-frailty: results from the gait and brain study. J Gerontol A Biol Sci Med Sci. 2016;71(11):1476–1482.
   PubMed Web of Science ®Google Scholar
• Canevelli M, Cesari M. Cognitive frailty: what is still missing? J Nutr Heal Aging. 2015;19(3):273–275.
   PubMed Web of Science ®Google Scholar
• Nakaya N, Mizuno K, Ohashi Y, et al. Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study). Drugs and Aging. [Internet]. 2011;28(9):681–692. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L362563580
   PubMed Web of Science ®Google Scholar
• Hurwitz A, Brady DA, Schaal SE, et al. Gastric acidity in older adults. Jama J Am Med Assoc. [Internet]. 1997 Aug 27 [cited 2016 Jul 5];278(8):659–662. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9272898
   PubMed Web of Science ®Google Scholar
• Stangier J, Rathgen K, Stahle H, et al. Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clin Pharmacokinet. [Internet]. 2010;49(4):259–268. Available from: http://ezproxy.library.usyd.edu.au/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=20214409
   PubMed Web of Science ®Google Scholar
• Mitchell SL, Rockwood K. The association between antiulcer medication and initiation of cobalamin replacement in older persons. J Clin Epidemiol. [Internet]. 2001 [cited 2016 Aug 10];54(5):531–534. Available from: http://www.sciencedirect.com/science/article/pii/S0895435600003401
   PubMed Web of Science ®Google Scholar
• Reeve E, Wiese MD, Mangoni AA. Alterations in drug disposition in older adults. Expert Opin Drug Metab Toxicol. 2015;11(4):491–508.
   PubMed Web of Science ®Google Scholar
• Merchant HA, Liu F, Orlu Gul M, et al. Age-mediated changes in the gastrointestinal tract. Int J Pharm. 2015;512(2):382–395.
   Web of Science ®Google Scholar
• Russell RM. Changes in gastrointestinal function attributed to aging. Am J Clin Nutr. 1992 [cited 1992 Jun 01];55(6 Suppl):1203s– 1207s.
   PubMed Web of Science ®Google Scholar
• Armbrecht HJ, Boltz MA, Kumar VB. Intestinal plasma membrane calcium pump protein and its induction by 1,25(OH)(2)D(3) decrease with age. Am J Physiol. [Internet]. 1999 Jul [cited 2016 Jul 5];277(1 Pt 1):G41–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10409149
   PubMed Web of Science ®Google Scholar
• Mangoni AA. The impact of advancing age on P-glycoprotein expression and activity: current knowledge and future directions. Expert Opin Drug Metab Toxicol. [Internet]. 2007 Jun [cited 2016 Jul 5];3(3):315–320. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17539740
   PubMed Web of Science ®Google Scholar
• Larsen U, Olesen H, Nyvold G. Human intestinal P‐glycoprotein activity estimated by the model substrate digoxin. J Clin Lab Invest. [Internet]. 2007 [cited 2016 Aug 25]. Available from: http://www.tandfonline.com/doi/abs/10.1080/00365510600986084
   Google Scholar
• Robertson DR, Waller DG, Renwick AG, et al. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol. [Internet]. 1988 Mar [cited 2016 Jul 5];25(3):297–305. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3358895
   PubMed Web of Science ®Google Scholar
• Ahmed AIA, Van Den Elsen GAH, Colbers A, et al. Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia. Psychopharmacology (Berl). [Internet]. 2015 [cited 2016 Jul 30];232(14):2587–2595. Available from: http://link.springer.com/article/10.1007/s00213-015-3889-y
   PubMed Web of Science ®Google Scholar
• Sousa T, Paterson R, Moore V, et al. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008;363:1–25.
   PubMed Web of Science ®Google Scholar
• Claesson MJ, Cusack S, O’Sullivan O, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA[Internet]. National Academy of Sciences. 2011 Mar 15 [cited 2016 Jul 11];108 Suppl(Supplement_1):4586–4591. Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.1000097107
   Web of Science ®Google Scholar
• Van Tongeren SP, Slaets JPJ, Harmsen HJM, et al. Fecal microbiota composition and frailty. Appl Environ Microbiol. [Internet]. American Society for Microbiology. 2005 Oct 1 [cited 2016 Jul 11];71(10). 6438–6442. Available from: http://aem.asm.org/cgi/doi/10.1128/AEM.71.10.6438-6442.2005
   PubMed Web of Science ®Google Scholar
• Thompson CM, Johns DO, Sonawane B, et al. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly. J Toxicol Environ Heal Part B Crit Rev. [Internet]. 2009;12(1):1–24. Available from: http://ezproxy.library.usyd.edu.au/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med5&AN=19117207
   PubMed Web of Science ®Google Scholar
• Hughes VA, Frontera WR, Wood M, et al. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci. [Internet]. 2001 May [cited 2016 Jul 11];56(5):B209–17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11320101
   PubMed Web of Science ®Google Scholar
• Rockwood K, Song X, MacKnight C. A global clinical measure of fitness and frailty - shortcut [Internet]. Can Med. 2005 [cited 2016 Jul 11]. Available from: https://www.cmaj.ca/content/173/5/489.full
   Google Scholar
• Hubbard RE, O’Mahony MS, Calver BL, et al. Nutrition, inflammation, and leptin levels in aging and frailty. J Am Geriatr Soc. [Internet]. Blackwell Publishing Inc. 2008 Feb [cited 2016 Jul 11];56(2):279–284. Available from: http://doi.wiley.com/10.1111/j.1532-5415.2007.01548.x
   PubMed Web of Science ®Google Scholar
• Ramsay SE, Arianayagam DS, Whincup PH, et al. Cardiovascular risk profile and frailty in a population-based study of older British men. Heart. [Internet]. BMJ Publishing Group Ltd and British Cardiovascular Society. 2015 Apr [cited 2016 Jul 11];101(8):616–622. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25480883
   PubMed Web of Science ®Google Scholar
• Gillette Guyonnet S, Abellan Van Kan G, Alix E, et al., R VB; IA on N and AEG. IANA (International academy on nutrition and aging) expert group: weight loss and Alzheimer’s disease. J Nutr Heal Aging. [Internet]. 2007 [cited 2016 Jul 27];11(1):38–48. Available from: http://search.proquest.com/openview/63b0469d433f6595e2a16befaade4d83/1?pq-origsite=gscholar
   PubMed Web of Science ®Google Scholar
• Wysokiński A, Sobów T, Kłoszewska I, et al. Mechanisms of the anorexia of aging—a review. Age (Dordr). 2015 Aug;37(4):9821. doi:10.1007/s11357-015-9821-x. Epub 2015 Aug 1.
   Google Scholar
• Hilmer SN. ADME-tox issues for the elderly. Expert Opin Drug Metab Toxicol. [Internet]. 2008;4(10):1321–1331. Available from: http://ezproxy.library.usyd.edu.au/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med5&AN=18798701
   PubMed Web of Science ®Google Scholar
• Benet L, Hoener B. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther. [Internet]. 2002 [cited 2016 Jul 11]. Available from: http://onlinelibrary.wiley.com/doi/10.1067/mcp.2002.121829/abstract
   Google Scholar
• Roberts J, Pea F, Lipman J. The clinical relevance of plasma protein binding changes. Clin Pharmacokinet. [Internet]. 2013 [cited 2016 Jul 28];52(1):1–8. Available from: http://link.springer.com/article/10.1007/s40262-012-0018-5
   PubMed Web of Science ®Google Scholar
• Campion EW, DeLabry LO, Glynn RJ. The effect of age on serum albumin in healthy males: report from the normative aging study. J Gerontol. [Internet]. 1988 Jan [cited 2016 Jul 28];43(1):M18–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3335748
   PubMedGoogle Scholar
• Le Couteur DG, Blyth FM, Creasey HM, et al. The association of alanine transaminase with aging, frailty, and mortality. J Gerontol A Biol Sci Med Sci. [Internet]. Oxford University Press. 2010 Jul [cited 2016 Jul 11];65(7):712–717. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20498223
   PubMed Web of Science ®Google Scholar
• Maes M, DeVos N, Wauters A, et al. Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer’s disease. J Psychiatr Res. [Internet]. 1999 [cited 2016 Jul 28];33(5):397–405. Available from: http://www.sciencedirect.com/science/article/pii/S0022395699000163
   PubMed Web of Science ®Google Scholar
• Crimmins E, Vasunilashorn S, Kim JK, et al. Biomarkers related to aging in human populations. Adv Clin Chem. [Internet]. 2008 [cited 2016 Jul 28];46:161–216. Available from: http://www.sciencedirect.com/science/article/pii/S0065242308004058
   PubMed Web of Science ®Google Scholar
• Cattin L, Bordin P, Fonda M, et al. Factors associated with cognitive impairment among older Italian inpatients. Gruppo Italiano di Farmacovigilanza nell’Anziano (G.I.F.A.). J - Am Geriatr Soc. [Internet]. Blackwell Publishing Ltd. 1997 Nov [cited 2016 Jul 28];45(11):1324–1330. Available from: http://doi.wiley.com/10.1111/j.1532-5415.1997.tb02931.x
   PubMed Web of Science ®Google Scholar
• Ng T-P, Feng L, Niti M, et al. Albumin, haemoglobin, BMI and cognitive performance in older adults. Age Ageing. [Internet]. Oxford University Press. 2008 Jul [cited 2016 Jul 28];37(4):423–429. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18495687
   PubMed Web of Science ®Google Scholar
• Duarte P, Duarte M, Pelichek A, et al. Cardiovascular risk factors and inflammatory activity among centenarians with and without dementia. Aging Clin. [Internet]. 2016 [cited 2016 Jul 28]. Available from: http://link.springer.com/article/10.1007/s40520-016-0603-9
   Google Scholar
• Israili ZH, Dayton PG. Human Alpha-1-Glycoprotein And Its Interactions With Drugs †,‡. Drug Metab Rev. [Internet]. Taylor & Francis. 2001 [cited 2016 Jul 28];33(2):161–235. Available from: http://www.tandfonline.com/doi/full/10.1081/DMR-100104402
   PubMed Web of Science ®Google Scholar
• Zhang R, Barker L, Pinchev D, et al. Mining biomarkers in human sera using proteomic tools. Proteomics. [Internet]. 2004 [cited 2016 Jul 28];4(1):244–256. Available from: http://onlinelibrary.wiley.com/doi/10.1002/pmic.200300495/full
   PubMed Web of Science ®Google Scholar
• German DC, Gurnani P, Nandi A, et al. Serum biomarkers for Alzheimer’s disease: proteomic discovery. Biomed Pharmacother. [Internet]. 2007 [cited 2016 Jul 28];61(7):383–389. Available from: http://www.sciencedirect.com/science/article/pii/S0753332207001138
   PubMed Web of Science ®Google Scholar
• Grandison MK, Boudinot FD. Age-related changes in protein binding of drugs: implications for therapy. Clinpharmacokinet. [Internet]. 2000 Mar [cited 2016 Jul 28];38(3):271–290. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10749520
   PubMed Web of Science ®Google Scholar
• Dasgupta A. Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management. [Internet]. Clinica Chimica Acta. 2007 [cited 2016 Jul 28];377:1–13. Available from: http://www.sciencedirect.com/science/article/pii/S0009898106005924
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. [Internet]. Nature Publishing Group. 2012; 32(11):1959–1972. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3494002&tool=pmcentrez&rendertype=abstract
   PubMed Web of Science ®Google Scholar
• Popescu B, Toescu E, Popescu L. Blood-brain barrier alterations in ageing and dementia. J Neurol Sci. [Internet]. 2009 [cited 2016 May 30]. Available from: http://www.sciencedirect.com/science/article/pii/S0022510X09004171
   Google Scholar
• Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease - systematic review and meta-analysis. Neurobiol Aging. 2009;30:337–352.
   PubMed Web of Science ®Google Scholar
• Mehta DC, Short JL, Hilmer SN, et al. Drug access to the central nervous system in Alzheimer’s disease: preclinical and clinical insights. [Internet]. Pharm Res. 2015 [cited 2016 Jul 29];32:819–839. Available from: http://link.springer.com/article/10.1007/s11095-014-1522-0
   PubMed Web of Science ®Google Scholar
• Toornvliet R, van Berckel BNM, Luurtsema G, et al. Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[11C]verapamil and positron emission tomography. Clin Pharmacol Ther. [Internet]. 2006 [cited 2016 Jul 29];79(6):540–548. Available from: http://onlinelibrary.wiley.com/doi/10.1016/j.clpt.2006.02.004/full
   PubMed Web of Science ®Google Scholar
• Warrington JS, Greenblatt DJ, von Moltke LL. The effect of age on P-glycoprotein expression and function in the fischer-344 rat. J Pharmacol Exp Ther. [Internet]. American Society for Pharmacology and Experimental Therapeutics. 2004 Feb 6 [cited 2016 Aug 29];309(2). 730–736. Available from: http://jpet.aspetjournals.org/cgi/doi/10.1124/jpet.103.061234
   PubMed Web of Science ®Google Scholar
• van Assema DME, Lubberink M, Bauer M, et al. Blood-brain barrier P-glycoprotein function in Alzheimer’s disease. Brain. [Internet]. 2012 Jan [cited 2016 Jul 29];135(Pt 1):181–189. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22120145
   PubMed Web of Science ®Google Scholar
• Deo AK, Borson S, Link JM, et al. Activity of P-glycoprotein, a β-amyloid transporter at the blood-brain barrier, is compromised in patients with mild Alzheimer disease. J Nucl Med. [Internet]. 2014 Jul [cited 2016 Jul 29];55(7):1106–1111. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24842892
   PubMed Web of Science ®Google Scholar
• Mehta DC, Short JL, Nicolazzo JA. Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer’s disease. Pharm Res. [Internet]. 2013 [cited 2016 Jul 29];30(11):2868–2879. Available from: http://link.springer.com/article/10.1007/s11095-013-1116-2
   PubMed Web of Science ®Google Scholar
• Molchan SE, Martinez RA, Hill JL, et al. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. [Internet]. Brain Res Rev. 1992 [cited 2016 Jul 29];17:215–226. Available from: http://www.sciencedirect.com/science/article/pii/016501739290017G
   PubMedGoogle Scholar
• Schliamser SE, Cars O, Norrby SR. Neurotoxicity of β-lactam antibiotics: predisposing factors and pathogenesis. J Antimicrob Chemother. [Internet]. Oxford University Press. 1991 [cited 2016 Jul 29];27(4):405–425. Available from: http://jac.oxfordjournals.org/cgi/doi/10.1093/jac/27.4.405
   PubMed Web of Science ®Google Scholar
• Reeves S. Mechanisms underpinning antipsychotic drug sensitivity in Alzheimer’s disease. Eur Neuropsychopharmacol. [Internet]. 2015 [cited 2016 Jun 20];25:S584–5. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L72129911\nhttp://resolver.ebscohost.com/openurl?custid=s3733374&authtype=ip&&sid=EMBASE&issn=0924977X&id=doi:&atitle=Mechanisms+underpinning+antipsychotic+drug+sensitivity+in+Alzhei
   Web of Science ®Google Scholar
• Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. [Internet]. 2009 [cited 2016 Jul 31];41(2):67–76. Available from: http://www.tandfonline.com/doi/abs/10.1080/03602530902722679
   PubMed Web of Science ®Google Scholar
• Krishna DR, Klotz U. Extrahepatic metabolism of drugs in humans. [Internet]. Clin Pharmacokinet. 1994 [cited 2016 Jul 31];26:144–160. Available from: http://link.springer.com/article/10.2165/00003088-199426020-00007
   PubMed Web of Science ®Google Scholar
• McLachlan AJ, Bath S, Naganathan V, et al. Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. Br J Clin Pharmacol. [Internet]. Blackwell Publishing Ltd. 2011 Mar [cited 2016 Jun 20];71(3):351–364. Available from: http://doi.wiley.com/10.1111/j.1365-2125.2010.03847.x
   PubMed Web of Science ®Google Scholar
• Butler JM, Begg EJ. Free drug metabolic clearance in elderly people. Clin Pharmacokinet. [Internet]. 2008 [cited 2016 Jul 28];47(5):297–321. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18399712
   PubMed Web of Science ®Google Scholar
• Le Couteur DG, McLean AJ. The aging liver: drug clearance and an oxygen diffusion barrier hypothesis. [Internet]. Clin Pharmacokinet. Springer International Publishing. 1998 [cited 2016 Jul 31];34:359–373. Available from: http://link.springer.com/10.2165/00003088-199834050-00003
   PubMed Web of Science ®Google Scholar
• Wynne HA, Cope LH, Mutch E, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology. [Internet]. W.B. Saunders. 1989 Feb [cited 2016 Jul 31];9(2):297–301. Available from: http://doi.wiley.com/10.1002/hep.1840090222
   PubMed Web of Science ®Google Scholar
• Le Couteur DG, Warren A, Cogger VC, et al. Old age and the hepatic sinusoid. Anat Rec. [Internet]. 2008 [cited 2016 Jul 31];291(6):672–683. Available from: http://onlinelibrary.wiley.com/doi/10.1002/ar.20661/full
   Google Scholar
• Le Couteur DG, Fraser R, Hilmer S, et al. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. [Internet]. Clin Pharmacokinet. 2005 [cited 2016 Jul 31];44:187–200. Available from: http://link.springer.com/article/10.2165/00003088-200544020-00004
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Cogger VC, Muller M, et al. The hepatic pharmacokinetics of doxorubicin and liposomal doxorubicin. Drug Metab Dispos. [Internet]. 2004 [cited 2016 Jul 31];32(8):794–799. Available from: http://dmd.aspetjournals.org/content/32/8/794.short
   PubMed Web of Science ®Google Scholar
• Mitchell SJ, Huizer-Pajkos A, Cogger VC, et al. The influence of old age and poloxamer-407 on the hepatic disposition of diazepam in the isolated perfused rat liver. Pharmacology. [Internet]. 2012 [cited 2016 Jul 31];90(5–6):233–241. Available from: http://www.karger.com/Article/Abstract/341724
   PubMed Web of Science ®Google Scholar
• Mitchell SJ, Huizer-Pajkos A, Cogger VC, et al. Age-related pseudocapillarization of the liver sinusoidal endothelium impairs the hepatic clearance of acetaminophen in rats. J Gerontol A Biol Sci Med Sci. [Internet]. Oxford University Press. 2011 Apr [cited 2016 Aug 10];66(4):400–408. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21300741
   PubMed Web of Science ®Google Scholar
• Tan JL, Eastment JG, Poudel A, et al. Age-related changes in hepatic function: an update on implications for drug therapy. Drugs Aging. [Internet]. 2015 [cited 2016 Jul 31];32(12):999–1008. Available from: http://link.springer.com/article/10.1007/s40266-015-0318-1
   PubMed Web of Science ®Google Scholar
• Cheluvappa R, Hilmer SN, Kwun SY, et al. The effect of old age on liver oxygenation and the hepatic expression of VEGF and VEGFR2. Exp Gerontol. [Internet]. 2007 [cited 2016 Aug 29];42(10):1012–1019. Available from: http://www.sciencedirect.com/science/article/pii/S0531556507001325
   PubMed Web of Science ®Google Scholar
• Cheluvappa R, Hilmer SN, Sun YK, et al. Effects of old age on hepatocyte oxygenation. Ann N. Y. Acad Sci. [Internet]. 2007 [cited 2016 Aug 29];88–92. Available from: http://onlinelibrary.wiley.com/doi/10.1196/annals.1396.007/full
   Google Scholar
• Hubbard RE, O’Mahony MS, Calver BL, et al. Plasma esterases and inflammation in ageing and frailty. Eur J Clin Pharmacol. [Internet]. Springer-Verlag. 2008 Sep 28 [cited 2016 Jul 30];64(9). 895–900. Available from: http://link.springer.com/10.1007/s00228-008-0499-1
   PubMed Web of Science ®Google Scholar
• Chang SS, Weiss CO, Xue QL, et al. Association between inflammatory-related disease burden and frailty: results from the Women’s Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr. [Internet]. NIH Public Access. 2012 [cited 2016 Aug 2];54(1):9–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21763008
   PubMed Web of Science ®Google Scholar
• Renton KW. Regulation of drug metabolism and disposition during inflammation and infection. Expert Opin Drug Metab Toxicol. [Internet]. 2005 [cited 2016 Jul 30];1:629–640. Available from: http://www.tandfonline.com/doi/abs/10.1517/17425255.1.4.629
   PubMedGoogle Scholar
• Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol. [Internet]. Annual Reviews. 2006 [cited 2016 Jul 30];46(1):123–149. Available from: http://www.annualreviews.org/doi/abs/10.1146/annurev.pharmtox.46.120604.141059
   PubMed Web of Science ®Google Scholar
• Rivory LP, Slaviero KA, Clarke SJ. Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response. Br J Cancer. [Internet]. Nature Publishing Group. 2002 Jul 23 [cited 2016 Aug 1];87(3). 277–280. Available from: http://www.nature.com/doifinder/10.1038/sj.bjc.6600448
   PubMed Web of Science ®Google Scholar
• Schwartz JB. Erythromycin breath test results in elderly, very elderly, and frail elderly persons. Clin Pharmacol Ther. [Internet]. 2006 [cited 2016 Jul 30];79(5):440–448. Available from: http://onlinelibrary.wiley.com/doi/10.1016/j.clpt.2006.01.006/full
   PubMed Web of Science ®Google Scholar
• Kurnik D, Wood AJJ, Wilkinson GR. The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity. Clin Pharmacol Ther. [Internet]. 2006 [cited 2016 Jul 31];80(3):228–234. Available from: http://onlinelibrary.wiley.com/doi/10.1016/j.clpt.2006.06.002/full
   PubMed Web of Science ®Google Scholar
• Abou-Hatab K, O’Mahony MS, Patel S, et al. Relationship between age and plasma esterases. Age Ageing. [Internet]. Oxford University Press. 2001 Jan 1 [cited 2016 Aug 1];30(1). 41–45. Available from: http://www.ageing.oupjournals.org/cgi/doi/10.1093/ageing/30.1.41
   PubMed Web of Science ®Google Scholar
• Williams FM. Serum enzymes of drug metabolism. Pharmacol Ther. [Internet]. Pergamon. 1987 Jan [cited 2016 Aug 1];34(1):99–109. Available from: http://linkinghub.elsevier.com/retrieve/pii/0163725887900945
   PubMed Web of Science ®Google Scholar
• Wynne HA, Cope LH, Herd B, et al. The association of age and frailty with paracetamol conjugation in man. Age Ageing. [Internet]. 1990 [cited 2016 Jul 30];19(6):419–424. Available from: http://ageing.oxfordjournals.org/content/19/6/419.short
   PubMed Web of Science ®Google Scholar
• Wynne HA, Yelland C, Cope LH, et al. The association of age and frailty with the pharmacokinetics and pharmacodynamics of metoclopramide. Age Ageing. [Internet]. 1993 [cited 2016 Jul 30];22(5):354–360. Available from: http://ageing.oxfordjournals.org/content/22/5/354.short
   PubMed Web of Science ®Google Scholar
• Mitchell SJ, Kane AE, Hilmer SN, et al. Age-related changes in the hepatic pharmacology and toxicology of paracetamol, age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res Curr Gerontol Geriatr Res. [Internet]. 2011 [cited 2016 Jul 30];2011:e624156. Available from: http://www.hindawi.com/journals/cggr/2011/624156/?b-FyVZLCEeGomgXnzYCADA&ved=0CCQQFjADOGQ&usg=AFQjCNF5IFBvib8lKftBWOQG2WMdASX93Q
   PubMedGoogle Scholar
• Kane AE, Mitchell SJ, Mach J, et al. Acetaminophen hepatotoxicity in mice: effect of age, frailty and exposure type. Exp Gerontol. 2016;73:95–106.
   PubMed Web of Science ®Google Scholar
• Mitchell SJ, Hilmer SN, Murnion BP, et al. Hepatotoxicity of therapeutic short-course paracetamol in hospital inpatients: impact of ageing and frailty. J Clin Pharm Ther. [Internet]. Blackwell Publishing Ltd. 2011 Jun [cited 2016 Aug 29];36(3):327–335. Available from: http://doi.wiley.com/10.1111/j.1365-2710.2010.01193.x
   PubMed Web of Science ®Google Scholar
• Cacabelos R. Pharmacogenomic protocols in CNS disorders and dementia. Neurodegenerative Dis. [Internet]. 2010 [cited 2016 Jun 7];167–169. Available from: http://www.karger.com/Article/Abstract/289230
   Google Scholar
• Mühlberg W, Platt D. Age-dependent changes of the kidneys: pharmacological implications. Gerontology. [Internet]. Karger Publishers. 1999 Aug 25 [cited 2016 Aug 1];45(5). 243–253. Available from: http://www.karger.com/?doi=10.1159/000022097
   PubMed Web of Science ®Google Scholar
• Sesso R, Prado F, Vicioso B, et al. Prospective study of progression of kidney dysfunction in community-dwelling older adults. Nephrology. [Internet]. Blackwell Publishing Asia. 2008 Mar [cited 2016 Aug 1];13(2):99–103. Available from: http://doi.wiley.com/10.1111/j.1440-1797.2008.00919.x
   PubMed Web of Science ®Google Scholar
• Aymanns C, Keller F, Maus S, et al. Review on pharmacokinetics and pharmacodynamics and the aging kidney. Clin J Am Soc Nephrol CJASN. [Internet]. 2010;5(2):314–327. Available from: http://ezproxy.library.usyd.edu.au/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=20056753
   PubMed Web of Science ®Google Scholar
• Ginsberg G, Hattis D, Russ A, et al. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals. Environ Health Perspect. [Internet]. 2005;113(9):1243–1249. Available from: http://ezproxy.library.usyd.edu.au/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med5&AN=16140636
   PubMed Web of Science ®Google Scholar
• Esposito C, Plati AR, Mazzullo T, et al. Renal function and functional reserve in healthy elderly individuals. J Nephrol. [Internet]. 2007 [cited 2016 Aug 2];20(5):617–625. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17918149
   PubMed Web of Science ®Google Scholar
• Schmitt R, Coca S, Kanbay M, et al. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis. 2008;52(2):262–271.
   PubMed Web of Science ®Google Scholar
• Johnston C, Hilmer SN, McLachlan AJ, et al. The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration. Eur J Clin Pharmacol. [Internet]. Springer Berlin Heidelberg. 2014 May 14 [cited 2016 Aug 1];70(5). 549–555. Available from: http://link.springer.com/10.1007/s00228-014-1652-7
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Stehman-Breen C, Fried LF, et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis. 2004;43(5):861–867.
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Tran K, Rubie P, et al. Gentamicin pharmacokinetics in old age and frailty. Br J Clin Pharmacol. [Internet]. Blackwell Publishing Ltd. 2011 Feb [cited 2016 Aug 29];71(2):224–231. Available from: http://doi.wiley.com/10.1111/j.1365-2125.2010.03825.x
   PubMed Web of Science ®Google Scholar
• Zuliani G, Galvani M, Sioulis F, et al. Discharge diagnosis and comorbidity profile in hospitalized older patients with dementia. Int J Geriatr Psychiatry. [Internet]. John Wiley & Sons, Ltd. 2012 Mar [cited 2016 Aug 1];27(3):313–320. Available from: http://doi.wiley.com/10.1002/gps.2722
   PubMed Web of Science ®Google Scholar
• Albert MS, Blacker D. Mild cognitive impairment and dementia. Annu Rev Clin Psychol. [Internet]. 2006 [cited 2016 Aug 2];2:379–388. Available from: http://data.aerzteblatt.org/pdf/DI/108/44/m743.pdf
   PubMed Web of Science ®Google Scholar
• Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: the cardiovascular health cognition study. J Am Soc Nephrol. [Internet]. American Society of Nephrology. 2004 Jul 1 [cited 2016 Aug 2];15(7):1904–1911. Available from: http://www.jasn.org/cgi/doi/10.1097/01.ASN.0000131529.60019.FA
   PubMed Web of Science ®Google Scholar
• Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. [Internet]. American Society of Nephrology. 2005 Apr 20 [cited 2016 Jul 11];16(7):2127–2133. Available from: http://www.jasn.org/cgi/doi/10.1681/ASN.2005010005
   PubMed Web of Science ®Google Scholar
• Alagiakrishnan K, Senthilselvan A. Low agreement between the modified diet and renal disease formula and the cockcroft-gault formula for assessing chronic kidney disease in cognitively impaired elderly outpatients. Postgrad Med. [Internet]. Taylor & Francis. 2010 Nov 13 [cited 2016 Aug 2];122(6). 41–45. Available from: http://www.tandfonline.com/doi/full/10.3810/pgm.2010.11.2221
   PubMed Web of Science ®Google Scholar
• Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. The Lancet. [Internet]. Europe PMC Funders. 2013 [cited 2016 Jun 27];752–762. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23395245
   Google Scholar
• McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. [Internet]. 2004;56(2):163–184. Available from: http://ezproxy.library.usyd.edu.au/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med5&AN=15169926
   PubMed Web of Science ®Google Scholar
• Hilmer SN. ADME-tox issues for the elderly. Expert Opin Drug Metab Toxicol. [Internet]. 2008 Oct [cited 2016 Jul 11];4(10):1321–1331. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18798701
   PubMed Web of Science ®Google Scholar
• Lassiter J, Bennett WM, Olyaei AJ. Drug dosing in elderly patients with chronic kidney disease. Clin Geriatr Med. [Internet]. 2013;29(3):657–705. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L369315933
   PubMed Web of Science ®Google Scholar
• Madsen JL. Effects of gender, age, and body mass index on gastrointestinal transit times. Dig Dis Sci. [Internet]. 1992 Oct [cited 2016 Aug 3];37(10):1548–1553. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1396002
   PubMed Web of Science ®Google Scholar
• Degen LP, Phillips SF, Izzo D. Variability of gastrointestinal transit in healthy women and men. Gut. [Internet]. 1996 Aug [cited 2016 Aug 3];39(2):299–305. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8977347
   PubMed Web of Science ®Google Scholar
• Grossman MI, Kirsner JB, Gillespie IE. Basal and histalog-stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastroenterology. [Internet]. 1963 Jul [cited 2016 Aug 3];45:14–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14046306
   PubMed Web of Science ®Google Scholar
• Gorski JC, Jones DR, Haehner-Daniels BD, et al. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Clin Pharmacol Ther. [Internet]. 1998 Aug [cited 2016 Aug 3];64(2):133–143. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9728893
   PubMed Web of Science ®Google Scholar
• Krecic-Shepard ME, Barnas CR, Slimko J, et al. Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans. J Clin Pharmacol. [Internet]. 2000 Mar [cited 2016 Aug 3];40(3):219–230. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10709150
   PubMed Web of Science ®Google Scholar
• Paine MF, Ludington SS, Chen ML, et al. Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression? Drug Metab Dispos. [Internet]. 2005 Mar [cited 2016 Aug 3];33(3):426–433. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15608139
   PubMed Web of Science ®Google Scholar
• Lopez-Ortega M, Arroyo P. Anthropometric characteristics and body composition in Mexican older adults: age and sex differences. Br J Nutr. [Internet]. 2016 Feb 14 [cited 2016 Aug 3];115(3):490–499. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26597049
   PubMed Web of Science ®Google Scholar
• Schwartz JB. The influence of sex on pharmacokinetics. [Internet]. Clin Pharmacokinet. Springer International Publishing. 2003 [[cited 2016 Aug 3]];42:107–121. Available from: http://link.springer.com/10.2165/00003088-200342020-00001
   PubMed Web of Science ®Google Scholar
• Tamminga WJ, Wemer J, Oosterhuis B, et al. CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences. Eur J Clin Pharmacol. [Internet]. 1999 May [cited 2016 Aug 3];55(3):177–184. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10379632
   PubMed Web of Science ®Google Scholar
• Aichhorn W, Weiss U, Marksteiner J, et al. Influence of age and gender on risperidone plasma concentrations. J Psychopharmacol. [Internet]. 2005 Jul [cited 2016 Aug 3];19(4):395–401. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15982995
   PubMed Web of Science ®Google Scholar
• McCune JS, Lindley C, Decker JL, et al. Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan. J Clin Pharmacol. [Internet]. 2001 Jul [cited 2016 Aug 3];41(7):723–731. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11452704
   PubMed Web of Science ®Google Scholar
• Bebia Z, Buch SC, Wilson JW, et al. Bioequivalence revisited: influence of age and sex on CYP enzymes. Clin Pharmacol Ther. [Internet]. 2004 Dec [cited 2016 Aug 3];76(6):618–627. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15592333
   PubMed Web of Science ®Google Scholar
• Scripture CD, Pieper JA. Clinical pharmacokinetics of fluvastatin. Clin Pharmacokinet. [Internet]. Springer International Publishing. 2001 [cited 2016 Aug 3];40(4):263–281. Available from: http://link.springer.com/10.2165/00003088-200140040-00003
   PubMed Web of Science ®Google Scholar
• Anderson GD. Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase. J Gender-Specific Med. [Internet]. 2002 [cited 2016 Aug 3];5(1):25–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11859684
   PubMedGoogle Scholar
• Ou-Yang DS, Huang SL, Wang W, et al. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population. Br J Clin Pharmacol. [Internet]. 2000 Feb [cited 2016 Aug 3];49(2):145–151. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10671909
   PubMed Web of Science ®Google Scholar
• Adehin A, Bolaji OO. Polymorphisms of CYP1A2 and CYP2A6 activity: phenotypes and the effect of age and sex in a Nigerian population. Drug Metab Pers Ther. [Internet]. 2015 Jan 1 [cited 2016 Aug 3];30(3):203–210. Available from: http://www.degruyter.com/view/j/dmdi.2015.30.issue-3/dmpt-2015-0001/dmpt-2015-0001.xml
   PubMedGoogle Scholar
• Oztekin S, Mavioglu O, Elar Z, et al. The effects of gender and menopause on serum lidocaine levels in smokers. Eur J Drug Metab Pharmacokinet. [Internet]. 2005 [cited 2016 Aug 3];30(4):231–234. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16435566
   PubMed Web of Science ®Google Scholar
• Yukawa E, Mine H, Higuchi S, et al. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens. J Pharm Pharmacol. [Internet]. 1992 Sep [cited 2016 Aug 3];44(9):761–765. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1360530
   PubMed Web of Science ®Google Scholar
• Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. [Internet]. 2004 [2004 Jul 24];52(8):1349–1354. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15271125
   PubMed Web of Science ®Google Scholar
• Pasqualetti G, Tognini S, Calsolaro V, et al. Potential drug? drug interactions in alzheimer patients with behavioral symptoms. [Internet]. Clin Interv Aging. 2015 [cited 2016 Apr 27];10:1457–1466. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26392756
   PubMed Web of Science ®Google Scholar
• Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother. [Internet]. 2007;5(3):263–303. Available from: http://ezproxy.library.usyd.edu.au/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med5&AN=17996666
   PubMedGoogle Scholar
• Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. [Internet]. 2010 [cited 2016 Jun 7];17(6):571–584. Available from: http://www.ingentaconnect.com/content/ben/cmc/2010/00000017/00000006/art00005
   PubMed Web of Science ®Google Scholar
• Xiao RP, Tomhave ED, Wang DJ, et al. Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest. [Internet]. 1998 [cited 2016 Aug 4];101(6):1273–1282. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC508681/
   PubMed Web of Science ®Google Scholar
• Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. [Internet]. 2001 [cited 2016 Aug 4];11–14. Available from: http://www.psychiatrist.com/JCP/article/Pages/2001/v62s21/v62s2103.aspx
   Google Scholar
• Bierer LM, Haroutunian V, Gabriel S, et al. Neurochemical correlates of dementia severity in Alzheimer’s disease: relative importance of the cholinergic deficits. J Neurochem. [Internet]. Blackwell Science Ltd. 2002 Nov 23 [cited 2016 Aug 4];64(2):749–760. Available from: http://doi.wiley.com/10.1046/j.1471-4159.1995.64020749.x
   Google Scholar
• Sunderland T, Tariot PN, Newhouse PA. Differential responsivity of mood, behavior and cognition to cholinergic agents in elderly neuropsychiatric populations. [Internet]. Brain Res Rev. 1988 [cited 2016 Jun 6];13:371–389. Available from: http://www.sciencedirect.com/science/article/pii/0165017388900136
   Google Scholar
• Salahudeen MS, Duffull SB, Nishtala PS. Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review. Drugs Aging. [Internet]. 2014;31(3):185–192. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24526293
   PubMed Web of Science ®Google Scholar
• McKeith I, Fairbairn A, Perry R, et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. [Internet]. BMJ Group. 1992 Sep 19 [cited 2016 Aug 11];305(6855). 673–678. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1356550
   PubMed Web of Science ®Google Scholar
• Ballard C, Grace J, Mckeith I, et al. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer ’ s disease Increased urinary retinol loss in children with severe infections. Lancet. [Internet]. 1998 [cited 2016 Aug 11];351:1032–1033. Available from: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)78999-6/abstract
   PubMed Web of Science ®Google Scholar
• Ballard C, Howard R. Neuroleptic drugs in dementia: benefits and harm. Nat Rev Neurosci. 2006;7(6):492–500.
   PubMed Web of Science ®Google Scholar
• Therapeutic Goods Administration Australian Government. Risperidone and risk of cerebrovascular adverse events in dementia patients. Med Saf Updat. [Internet]. 2015;6(4):1–2. Available from: https://www.tga.gov.au/publication-issue/medicines-safety-update-volume-6-number-4-august-2015
   Google Scholar
• Banerjee S. The use of antipsychotic medication for people with dementia: time for action. [Internet]. Department of Health; 2009 [cited 2016 Jun 7]. p. 60. Available from: http://psychrights.org/research/digest/nlps/banerjeereportongeriatricneurolepticuse.pdf
   Google Scholar
• Cole LJ, Farrell MJ, Duff EP, et al. Pain sensitivity and fMRI pain-related brain activity in Alzheimer’s disease. Brain. [Internet]. 2006 [cited 2016 Aug 4];129(11):2957–2965. Available from: http://brain.oxfordjournals.org/content/129/11/2957.short
   PubMed Web of Science ®Google Scholar
• Benedetti F, Arduino C, Costa S, et al. Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain. [Internet]. 2006 [cited 2016 Aug 4];121(1–2):133–144. Available from: http://www.sciencedirect.com/science/article/pii/S030439590500638X
   PubMed Web of Science ®Google Scholar
• Schmucker DL. Liver function and phase I drug metabolism in the elderly. Drugs Aging. [Internet]. Springer International Publishing. 2001 cited 2016 Aug 5;18(11):837–851. Available from: http://link.springer.com/10.2165/00002512-200118110-00005
   PubMed Web of Science ®Google Scholar
• Nelson E, Dannefer D. Aged heterogeneity: fact or fiction? The fate of diversity in gerontological research. Gerontologist. [Internet]. 1992 [cited 2016 Aug 5]. Available from: http://gerontologist.oxfordjournals.org/content/32/1/17.short
   Google Scholar
• Groen K, Horan MA, Roberts NA, et al. The relationship between phenazone (Antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women. Clin Pharmacokinet. [Internet]. Springer International Publishing. 1993 Aug [cited 2016 Jul 30];25(2):136–144. Available from: http://link.springer.com/10.2165/00003088-199325020-00006
   PubMed Web of Science ®Google Scholar
• Noetzli M, Eap CB. Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer’s disease. Clin Pharmacokinet. [Internet]. 2013 [cited 2016 May 30];52(4):225–241. Available from: http://link.springer.com/article/10.1007/s40262-013-0038-9
   PubMed Web of Science ®Google Scholar
• Lozupone M, Panza F, Stella E, et al. Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come? [Internet]. Expert Opin Drug Metab Toxicol. 2017 [cited 2017 Apr 3];13:259–277. Available from: https://www.tandfonline.com/doi/full/10.1080/17425255.2017.1246533
   PubMed Web of Science ®Google Scholar
• Xiao T, Jiao B, Zhang W, et al. Effect of the CYP2D6 and APOE polymorphisms on the efficacy of Donepezil in patients with Alzheimer’s disease: a systematic review and meta-analysis. CNS Drugs. [Internet]. Springer International Publishing. 2016 Jun 9 [cited 2016 Jun 23];1–9. Available from: http://link.springer.com/10.1007/s40263-016-0356-1
   Google Scholar
• Wilson R, Weir D, Leurgans S, et al. Sources of variability in estimates of the prevalence of Alzheimer’s disease in the United States. Alzheimer’s & Dementia. [Internet]. 2011 [cited 2016 Aug 5]. Available from: http://www.sciencedirect.com/science/article/pii/S1552526010025082
   Google Scholar
• Kane AE, Hilmer SN, Boyer D, et al. Impact of longevity interventions on a validated mouse clinical frailty index. J Gerontol Ser Biol Sci Med Sci. [Internet]. Oxford University Press. 2016 Mar [cited 2016 Aug 5];71(3):333–339. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25711530
   PubMed Web of Science ®Google Scholar
• McGonigle P. Animal models of CNS disorders. Biochem Pharmacol. [Internet]. 2014 [cited 2016 Aug 5];87(1):140–149. Available from: http://www.sciencedirect.com/science/article/pii/S0006295213003870
   PubMed Web of Science ®Google Scholar
• Hajjar ER, Hanlon JT, Artz MB, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother. [Internet]. 2003 [cited 2016 Jun 6];1(2):82–89. Available from: http://www.sciencedirect.com/science/article/pii/S1543594603900043
   PubMedGoogle Scholar
• Tiseo P, Perdomo C, Friedhoff L. Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses. Br J Clin. [Internet]. 1998 [cited 2016 Aug 12]. Available from: https://www.researchgate.net/profile/Lawrence_Friedhoff2/publication/13447442_Concurrent_administration_of_donepezil_HCL_and_ketoconazole_Assessment_of_pharmacokinetic_changes_following_single_and_multiple_doses/links/53e4d90c0cf25d674e94f967.pdf
   Google Scholar
• Kanagaratnam L, Mahmoudi R, Novella JL, et al. Adverse drug reactions in elderly subjects hospitalized in a specialized dementia management unit. Drugs and Aging. [Internet]. 2014 Oct [cited 2016 Jun 6];31(10):769–776. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25200414
   PubMed Web of Science ®Google Scholar
• Ganjavi H, Herrmann N, Rochon PA, et al. Adverse drug events in cognitively impaired elderly patients. Dement Geriatr Cogn Disord. [Internet]. 2007 [cited 2016 Jun 6];23(6):395–400. Available from: http://www.karger.com/Article/Fulltext/101454
   PubMed Web of Science ®Google Scholar
• Onder G, Gambassi G, Scales J, et al. Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol. [Internet]. 2002 [cited 2016 Jun 6];58(5):371. Available from: http://link.springer.com/article/10.1007/s00228-002-0493-y
   PubMed Web of Science ®Google Scholar
• Rockwood K, Fay S, Jarrett P, et al. Effect of galantamine on verbal repetition in AD: A secondary analysis of the VISTA trial. Neurology. [Internet]. Lippincott Williams & Wilkins. 2007 Apr 3 [cited 2016 Jul 22];68(14). 1116–1121. Available from: http://www.neurology.org/cgi/doi/10.1212/01.wnl.0000258661.61577.b7
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. [Internet]. 2015 Nov [cited 2017 Apr 3];63(11):2227–2246. Available from: http://doi.wiley.com/10.1111/jgs.13702
   PubMed Web of Science ®Google Scholar
• O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. [Internet]. 2015 Mar [cited 2017 Apr 3];44(2):213–218. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25324330
   PubMed Web of Science ®Google Scholar
• Kröger E, Wilchesky M, Marcotte M, et al. Medication use among nursing home residents with severe dementia: identifying categories of appropriateness and elements of a successful intervention. J Am Med Dir Assoc. 2015;16(7):629.e1–629.e17.
   PubMed Web of Science ®Google Scholar
• Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. [Internet]. 2015; 175(5):827–834. DOI:10.1001/jamainternmed.2015.0324
   PubMed Web of Science ®Google Scholar
• Reeve E, Bell S, Hilmer SN. Barriers to optimising prescribing and deprescribing in older adults with dementia: a narrative review. Curr Clin Pharmacol. 2014;10(3):168–177.
   Web of Science ®Google Scholar